D Schrag

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Age and adjuvant chemotherapy use after surgery for stage III colon cancer
    D Schrag
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Natl Cancer Inst 93:850-7. 2001
  2. ncbi request reprint Influence of hospital procedure volume on outcomes following surgery for colon cancer
    D Schrag
    Department of Epidemiology and Biostatistics, Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    JAMA 284:3028-35. 2000
  3. doi request reprint Meeting the 12 lymph node (LN) benchmark in colon cancer
    A Rajput
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Surg Oncol 102:3-9. 2010
  4. ncbi request reprint Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare
    D Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:3712-8. 2001
  5. ncbi request reprint Young age influences treatment but not outcome of colon cancer
    H M Quah
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 14:2759-65. 2007
  6. ncbi request reprint The influence of hospital volume on survival after resection for lung cancer
    P B Bach
    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    N Engl J Med 345:181-8. 2001
  7. doi request reprint Use of high technology imaging for surveillance of early stage breast cancer
    K S Panageas
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, 3rd Floor, New York, NY 10021, USA
    Breast Cancer Res Treat 131:663-70. 2012
  8. ncbi request reprint Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation
    P B Bach
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Blood 98:3234-40. 2001
  9. doi request reprint Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer
    M J Gollub
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Eur Radiol 22:821-31. 2012

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Age and adjuvant chemotherapy use after surgery for stage III colon cancer
    D Schrag
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Natl Cancer Inst 93:850-7. 2001
    ..However, the extent to which adjuvant therapy is used outside the clinical trial setting, particularly among the elderly, is unknown...
  2. ncbi request reprint Influence of hospital procedure volume on outcomes following surgery for colon cancer
    D Schrag
    Department of Epidemiology and Biostatistics, Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    JAMA 284:3028-35. 2000
    ..Conflicting evidence exists as to whether the association between hospital experience and favorable health outcomes also applies to more frequently performed operations, such as those for colon cancer...
  3. doi request reprint Meeting the 12 lymph node (LN) benchmark in colon cancer
    A Rajput
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Surg Oncol 102:3-9. 2010
    ..Examining >or=12 LN in colon cancer has been suggested as a quality metric. The purpose of this study was to determine whether the 12 LN benchmark is achieved at NCCN centers compared to a US population-based sample...
  4. ncbi request reprint Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare
    D Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:3712-8. 2001
    ..To examine the relationship between patient characteristics and the use of adjuvant pelvic radiation with and without chemotherapy among patients aged 65 years and older with stage II and III rectal cancer...
  5. ncbi request reprint Young age influences treatment but not outcome of colon cancer
    H M Quah
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 14:2759-65. 2007
    ..The aim of this study was to determine the association between age, clinicopathologic features, adjuvant therapy, and outcomes following colon cancer resection...
  6. ncbi request reprint The influence of hospital volume on survival after resection for lung cancer
    P B Bach
    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    N Engl J Med 345:181-8. 2001
    ....
  7. doi request reprint Use of high technology imaging for surveillance of early stage breast cancer
    K S Panageas
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, 3rd Floor, New York, NY 10021, USA
    Breast Cancer Res Treat 131:663-70. 2012
    ..Strategies to foster judicious utilization of HTRI should be a priority...
  8. ncbi request reprint Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation
    P B Bach
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Blood 98:3234-40. 2001
    ..The presence of this feature may justify the recommendation to withdraw life-sustaining measures...
  9. doi request reprint Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer
    M J Gollub
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Eur Radiol 22:821-31. 2012
    ..To determine the ability of dynamic contrast enhanced (DCE-MRI) to predict pathological complete response (pCR) after preoperative chemotherapy for rectal cancer...